143 related articles for article (PubMed ID: 8980909)
21. Calcitriol-mediated modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2.
Kole KL; Gyetko MR; Simpson RU; Sitrin RG
Biochem Pharmacol; 1991 Feb; 41(4):585-91. PubMed ID: 1900005
[TBL] [Abstract][Full Text] [Related]
22. Retinoic acid priming potentiates the induction of urokinase-type plasminogen activator by cyclic adenosine monophosphate in mouse mammary carcinoma cells.
Mira-y-Lopez R
J Cell Physiol; 1991 Apr; 147(1):46-54. PubMed ID: 1645361
[TBL] [Abstract][Full Text] [Related]
23. Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
Niiya M; Niiya K; Kiguchi T; Shibakura M; Asaumi N; Shinagawa K; Ishimaru F; Kiura K; Ikeda K; Ueoka H; Tanimoto M
Cancer Chemother Pharmacol; 2003 Nov; 52(5):391-8. PubMed ID: 12908082
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor regulation of endothelial cell extracellular proteolysis: the role of urokinase plasminogen activator.
Niedbala MJ; Stein-Picarella M
Biol Chem Hoppe Seyler; 1992 Jul; 373(7):555-66. PubMed ID: 1381189
[TBL] [Abstract][Full Text] [Related]
25. Diversity and similarity in signaling events leading to rapid Cox-2 induction by tumor necrosis factor-alpha and phorbol ester in human endothelial cells.
Eligini S; Barbieri SS; Cavalca V; Camera M; Brambilla M; De Franceschi M; Tremoli E; Colli S
Cardiovasc Res; 2005 Feb; 65(3):683-93. PubMed ID: 15664395
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells.
Hamaguchi E; Takamura T; Shimizu A; Nagai Y
J Pharmacol Exp Ther; 2003 Dec; 307(3):987-94. PubMed ID: 14534369
[TBL] [Abstract][Full Text] [Related]
27. LY290181, an inhibitor of diabetes-induced vascular dysfunction, blocks protein kinase C-stimulated transcriptional activation through inhibition of transcription factor binding to a phorbol response element.
Birch KA; Heath WF; Hermeling RN; Johnston CM; Stramm L; Dell C; Smith C; Williamson JR; Reifel-Miller A
Diabetes; 1996 May; 45(5):642-50. PubMed ID: 8621017
[TBL] [Abstract][Full Text] [Related]
28. Kunitz-type protease inhibitor bikunin disrupts phorbol ester-induced oligomerization of CD44 variant isoforms containing epitope v9 and subsequently suppresses expression of urokinase-type plasminogen activator in human chondrosarcoma cells.
Suzuki M; Kobayashi H; Fujie M; Nishida T; Takigawa M; Kanayama N; Terao T
J Biol Chem; 2002 Mar; 277(10):8022-32. PubMed ID: 11777908
[TBL] [Abstract][Full Text] [Related]
29. Tumor necrosis factor-alpha stimulates fractalkine production by mesangial cells and regulates monocyte transmigration: down-regulation by cAMP.
Chen YM; Lin SL; Chen CW; Chiang WC; Tsai TJ; Hsieh BS
Kidney Int; 2003 Feb; 63(2):474-86. PubMed ID: 12631113
[TBL] [Abstract][Full Text] [Related]
30. TNF-α induces expression of urokinase-type plasminogen activator and β-catenin activation through generation of ROS in human breast epithelial cells.
Kim MJ; Kim DH; Na HK; Surh YJ
Biochem Pharmacol; 2010 Dec; 80(12):2092-100. PubMed ID: 20804741
[TBL] [Abstract][Full Text] [Related]
31. Structure and function analysis of urinary trypsin inhibitor (UTI): identification of binding domains and signaling property of UTI by analysis of truncated proteins.
Suzuki M; Kobayashi H; Tanaka Y; Hirashima Y; Terao T
Biochim Biophys Acta; 2001 May; 1547(1):26-36. PubMed ID: 11343788
[TBL] [Abstract][Full Text] [Related]
32. Cytokine activation of human macro- and microvessel-derived endothelial cells.
Gerritsen ME; Niedbala MJ; Szczepanski A; Carley WW
Blood Cells; 1993; 19(2):325-39; discussion 340-2. PubMed ID: 7906155
[TBL] [Abstract][Full Text] [Related]
33. Phorbol 12-myristate 13-acetate protects against tumor necrosis factor (TNF)-induced necrotic cell death by modulating the recruitment of TNF receptor 1-associated death domain and receptor-interacting protein into the TNF receptor 1 signaling complex: Implication for the regulatory role of protein kinase C.
Byun HS; Park KA; Won M; Yang KJ; Shin S; Piao L; Kwak JY; Lee ZW; Park J; Seok JH; Liu ZG; Hur GM
Mol Pharmacol; 2006 Sep; 70(3):1099-108. PubMed ID: 16798936
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of the soluble and the tumor cell receptor-bound plasmin by urinary trypsin inhibitor and subsequent effects on tumor cell invasion and metastasis.
Kobayashi H; Shinohara H; Takeuchi K; Itoh M; Fujie M; Saitoh M; Terao T
Cancer Res; 1994 Feb; 54(3):844-9. PubMed ID: 8306348
[TBL] [Abstract][Full Text] [Related]
35. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA).
Kobayashi H; Schmitt M; Goretzki L; Chucholowski N; Calvete J; Kramer M; Günzler WA; Jänicke F; Graeff H
J Biol Chem; 1991 Mar; 266(8):5147-52. PubMed ID: 1900515
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor.
Falcone DJ; McCaffrey TA; Haimovitz-Friedman A; Garcia M
J Cell Physiol; 1993 Jun; 155(3):595-605. PubMed ID: 7684044
[TBL] [Abstract][Full Text] [Related]
37. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of macrophage urokinase expression by polyanions is protein kinase C-dependent and requires protein and RNA synthesis.
Falcone DJ; McCaffrey TA; Vergilio JA
J Biol Chem; 1991 Nov; 266(33):22726-32. PubMed ID: 1658006
[TBL] [Abstract][Full Text] [Related]
39. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels.
Calderon TM; Factor SM; Hatcher VB; Berliner JA; Berman JW
Lab Invest; 1994 Jun; 70(6):836-49. PubMed ID: 8015288
[TBL] [Abstract][Full Text] [Related]
40. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
McGowen R; Biliran H; Sager R; Sheng S
Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
